CD3D and neoplasm: These ROIs were selected based on the presence of PanCK+ tumor regions directly adjacent to dense CD3D+ and CD68+ immune infiltrates, identified through both H&E and multiplex immunofluorescence staining, to capture tumor margins involved in immune interaction.